Dr. Brian Rini and Professor Tom Powles discuss the data and ongoing studies with the IL-6 antibody tocilizumab with Dr. Nick Mark, a pulmonary critical care specialist in Seattle. Dr. Mark shares tocilizumab’s capabilities across multiple indications, including CRS and KICS, and its potential against COVID-19.